Literature DB >> 12045193

The crystal structure of metal-free human EF-hand protein S100A3 at 1.7-A resolution.

Gunter Fritz1, Peer R E Mittl, Milan Vasak, Markus G Grutter, Claus W Heizmann.   

Abstract

S100A3 is a unique member of the EF-hand superfamily of Ca(2+)-binding proteins. It binds Ca(2+) with poor affinity (K(d) = 4-35 mm) but Zn(2+) with exceptionally high affinity (K(d) = 4 nm). This high affinity for Zn(2+) is attributed to the unusual high Cys content of S100A3. The protein is highly expressed in fast proliferating hair root cells and astrocytoma pointing toward a function in cell cycle control. We determined the crystal structure of the protein at 1.7 A. The high resolution structure revealed a large distortion of the C-terminal canonical EF-hand, which most likely abolishes Ca(2+) binding. The crystal structure of S100A3 allows the prediction of one putative Zn(2+) binding site in the C terminus of each subunit of S100A3 involving Cys and His residues in the coordination of the metal ion. Zn(2+) binding induces a large conformational change in S100A3 perturbing the hydrophobic interface between two S100A3 subunits, as shown by size exclusion chromatography and CD spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045193     DOI: 10.1074/jbc.M200574200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Binding of transition metals to S100 proteins.

Authors:  Benjamin A Gilston; Eric P Skaar; Walter J Chazin
Journal:  Sci China Life Sci       Date:  2016-07-19       Impact factor: 6.038

2.  Purification and crystallization of the human EF-hand tumour suppressor protein S100A2.

Authors:  Michael Koch; Joachim Diez; Günter Fritz
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

3.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

4.  Solution structure and dynamics of human S100A14.

Authors:  Ivano Bertini; Valentina Borsi; Linda Cerofolini; Soumyasri Das Gupta; Marco Fragai; Claudio Luchinat
Journal:  J Biol Inorg Chem       Date:  2012-11-30       Impact factor: 3.358

5.  Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate.

Authors:  Bin Liu; Wen-Yi Sun; Chen-Yang Zhi; Tian-Cheng Lu; Hai-Mei Gao; Jian-Hua Zhou; Wei-Qun Yan; Hai-Cheng Gao
Journal:  Exp Ther Med       Date:  2013-10-14       Impact factor: 2.447

6.  Multiple Evolutionary Origins of Ubiquitous Cu2+ and Zn2+ Binding in the S100 Protein Family.

Authors:  Lucas C Wheeler; Micah T Donor; James S Prell; Michael J Harms
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate.

Authors:  Ran Tao; Zhong-Feng Wang; Wei Qiu; Yu-Fang He; Wei-Qun Yan; Wen-Yi Sun; Hai-Jun Li
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

8.  Intrinsically disordered and aggregation prone regions underlie β-aggregation in S100 proteins.

Authors:  Sofia B Carvalho; Hugo M Botelho; Sónia S Leal; Isabel Cardoso; Günter Fritz; Cláudio M Gomes
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

9.  Optimal Mutant Model of Human S100A3 Protein Citrullinated at Arg51 by Peptidylarginine Deiminase Type III and Its Solution Structural Properties.

Authors:  Kenji Ite; Kento Yonezawa; Kenichi Kitanishi; Nobutaka Shimizu; Masaki Unno
Journal:  ACS Omega       Date:  2020-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.